Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Abrocitinib may effectively treat Lichen Planopilaris.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Ocrelizumab may cause delayed hair loss in some patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Upadacitinib effectively treats psoriasis and lichen planus together.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.